Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA
Summary Financials
Twist Bioscience Corp — SlamSEC
Revenue
$245.1M
+20.4% YoY
FY 2025
Adj. EBITDA
-$187.8M
-76.6% margin
FY 2025
Net Income
-$204.6M
-83.5% margin
FY 2025
EPS (Diluted)
-$3.60
FY 2025
Stock Price
$48.33
+2.9%
2026-03-09
52W Range
$23.30 – $57.88
P/E Ratio
-13.4x
Market Cap
$3.0B
Cash
$226.3M
FY 2025
Total Debt
$1.4M
FY 2021
Net Cash
$224.9M
FY 2021
Enterprise Value
$2.7B
Debt / EBITDA
1.2x
FY 2025
EV / EBITDA
-14.6x
Employees
—
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.